The invention provides novel spirotetrahydronaphthalene compounds of Formula α that inhibit β-secretase cleavage of APP and are useful as therapeutic agents for treating neurodegenerative diseases.
-
(2011/10/13)
More Articles about upstream products of 1338092-32-2
Get Best Price for1338092-32-22-amino-7''-(3-chlorophenyl)-1-methyl-2',3',5',6'-tetrahydro-3'',4''-dihydro-2''H-dispiro[imidazol-4,1''-naphthalen-3'',4'-pyran]-5(1H)-one